ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Indiana » Nephrology

Top Nephrology Prescribers in Indiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
VIJAY BHASIN M.D.

Nephrology

6,556

$445K

614
429 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $113

THERESA TRAVIS M.D.

Nephrology

6,472

$613K

306
226 are 65+

8%
patients receiving schedule two controlled substances

Avg: 0%

17%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 25%

$95
Average prescription price

Avg: $113

IRFAN MUNIR

Nephrology

5,573

$624K

482
344 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 25%

$112
Average prescription price

Avg: $113

MANISH GERA MBBS

Nephrology

5,417

$765K

446
308 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 25%

$141
Average prescription price

Avg: $113

SWAPNA JOSEPH MD

Nephrology

5,219

$279K

488
367 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $113

MARK RUMANCIK MD

Nephrology

5,216

$483K

495
376 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 25%

$93
Average prescription price

Avg: $113

PAUL SHIN MD

Nephrology

5,163

$221K

399
303 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 25%

$43
Average prescription price

Avg: $113

BARBARA HAEHNER M.D.

Nephrology

4,968

$531K

264
166 are 65+

7%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 25%

$107
Average prescription price

Avg: $113

JOHN DUCKER MD

Nephrology

4,579

$423K

347
203 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 25%

$92
Average prescription price

Avg: $113

KUPUSAMY UMAPATHY M.D.

Nephrology

4,531

$660K

291
171 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 25%

$146
Average prescription price

Avg: $113

AKRAM AL-MAKKI MD

Nephrology

4,491

$194K

343
300 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 25%

$43
Average prescription price

Avg: $113

RAYMOND KISER M.D.

Nephrology

4,335

$429K

422
302 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 25%

$99
Average prescription price

Avg: $113

MUHAMMAD YAQUB M.D.

Nephrology

4,286

$261K

194
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $113

ASIF SHARFUDDIN M.D.

Nephrology

4,212

$346K

184
50 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 25%

$82
Average prescription price

Avg: $113

GEOFFREY GOLEMBIEWSKI MD

Nephrology

4,118

$268K

252
201 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

13%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $113

CHARLES CARTER M.D.

Nephrology

3,851

$251K

223
96 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $113

ARIF GOREJA MD

Nephrology

3,703

$188K

343
250 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $113

ANIL JAIN M.D

Nephrology

3,590

$302K

332
243 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 25%

$84
Average prescription price

Avg: $113

RABIH KALAKECHE

Nephrology

3,460

$113K

293
239 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 25%

$33
Average prescription price

Avg: $113

MAHENDRA GOVANI M.D.

Nephrology

3,418

$202K

95
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $113

MAHER AJAM M.D.

Nephrology

3,376

$492K

268
174 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 25%

$146
Average prescription price

Avg: $113

THOMAS GOLUBSKI MD

Nephrology

3,352

$424K

326
238 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 25%

$126
Average prescription price

Avg: $113

JAMES SUTTON MD

Nephrology

3,338

$244K

247
180 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 25%

$73
Average prescription price

Avg: $113

SHAHABUL ARFEEN M.D.

Nephrology

3,309

$402K

228
138 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 25%

$122
Average prescription price

Avg: $113

JAMES PORILE MD

Nephrology

3,303

$626K

343
211 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 25%

$189
Average prescription price

Avg: $113

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank